AKAnna KovalMDVideoHIVRSVHIV Care in Ukraine WebinarHIV Care in Ukraine - HIV Care Continuum in Ukraine Before and During the War EN - Dr. Anna KovalView Video
SASergii AntoniakMDVideoHIVRSVHIV Care in Ukraine WebinarHIV Care in Ukraine - Emergency Response to New Challenges in HIV Care in Ukraine EN - Dr. Sergii AntoniakView Video
AKAndriy KlepikovPhDVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisHIV Care in Ukraine WebinarHIV Care in Ukraine - Healthcare Situation in Ukraine EN - Dr. Andriy KlepikovView Video
FMFiona MarraMPharm, FRPharmS, PhD, MScVideoRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 | Fiona Marra, MPharm, MScView Video
CMCatia MarzoliniPharmD, PhDVideoRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 | Catia Marzolini, PharmD, PhDView Video
DBDavid BurgerPharmD, PhDVideoRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Oral Antivirals for COVID-19: Drug-Drug Interactions as a Manageable Risk | David Burger, PharmD, PhDView Video
GDPGiovanni Di PerriMD, PhDVideoRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Oral Antivirals for COVID-19: How to Best Make Use of Their Therapeutic Effects | Giovanni Di Perri, MD, PhDView Video
FMFiona MarraMPharm, FRPharmS, PhD, MScSlidesetRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 - Fiona Marra, MPharm, MScView Slideset
CMCatia MarzoliniPharmD, PhDSlidesetRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 - Catia Marzolini, PharmD, PhDView Slideset
DBDavid BurgerPharmD, PhDSlidesetRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Oral Antivirals for COVID-19: Drug-Drug Interactions as a Manageable Risk - David Burger, PharmD, PhDView Slideset
GDPGiovanni Di PerriMD, PhDSlidesetRSVCOVID-19Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022Oral Antivirals for COVID-19: How to Best Make Use of Their Therapeutic Effects - Giovanni Di Perri, MD, PhDView Slideset
